| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |